Skip to main content

Share story

Science

Orphan Therapeutics Accelerator licenses shelved clinical gene therapy

Orphan Therapeutics Accelerator licenses shelved clinical gene therapy Image: Primary
Orphan Therapeutics Accelerator has licensed an investigational gene therapy for ornithine transcarbamylase deficiency from UCL Ventures and Children's Medical Research Institute, GEN reported. The nonprofit's first licensed therapy, now called OTXL-101, had returned to its developers after its previous licensee, Bloomsbury Genetic Therapies, shut down in 2025. The treatment uses a liver-targeted virus to deliver a functional gene for an enzyme needed to clear ammonia. One patient received it in a Phase I/II trial in December 2023. OTXL is testing the stability and potency of previously manufactured material and seeking additional funding to advance development.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from GEN - Genetic Engineering and Biotechnology News and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Science Infrastructure
Science Infrastructure

Researchers demonstrate temperature sensor powered by nearby electrical wiring

Researchers at the University of Arkansas and the University of Michigan demonstrated a battery-free temperature sensor powered by energy captured from magnetic fields near electrical wiring, New Atlas reports.

Science
Science

MIT modules retain electrical connections as structures change shape

MIT researchers and collaborators have developed 3D-printed modules that change shape while maintaining electrical connections, New Atlas reports. The team's design endured 10,000 compressions without losing electrical connection during testing.

Science
Science

Two-ion experiment simulates how quantum flux controls particle motion

University of Oxford researchers demonstrated how quantum flux can stop particle motion in a simulated lattice gauge theory, using two trapped ions, Phys.org reported. The experiment extends beyond one-dimensional setups that cannot capture effects associated with magnetic flux.

Science Infrastructure
Science Infrastructure

IBM, AMD and Oak Ridge announce colocated quantum error-correction platform

IBM, AMD and Oak Ridge National Laboratory's Quantum Science Center unveiled a platform this week that will place quantum computers alongside classical high-performance computing systems to research error correction.